Gijs Schröder

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)
Jeroen H A Creemers, Ankur Ankan, Kit C B Roes, Gijs Schröder, Niven Mehra, Carl G Figdor, Ingrid Jolanda M De Vries, Johannes C Textor
In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome. Nature communications 14 (1) (2023)